Design, synthesis, and biological evaluation of new carbamothioylhydrazineylidene-indole-acetamide hybrids as cholinesterase inhibitors with metal-chelating properties for potential application in Alzheimer's disease


Dastyafteh N., Motamedi Shakib N., Niloufar Ghafouri S., Ahmad I., Patel ., Mohammadi-Khanaposhtani M., ...Daha Fazla

Journal of Molecular Structure, cilt.148131, ss.1-20, 2026 (Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 148131
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1016/j.molstruc.2026.148131
  • Dergi Adı: Journal of Molecular Structure
  • Derginin Tarandığı İndeksler: Applied Science & Technology Source, Scopus
  • Sayfa Sayıları: ss.1-20
  • İnönü Üniversitesi Adresli: Evet

Özet

In the search for novel agents for the treatment of Alzheimer’s disease (AD), we designed and synthesized a new library of carbamothioylhydrazineylidene-indole-acetamide derivatives 7a-7n using a hybridization strategy that integrates three well-established pharmacophores for cholinesterase inhibition. The compounds were evaluated for their inhibitory activity against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) along with their Fe2+ chelation capacity. Biological assays demonstrated that all compounds 7a-7n exhibited stronger AChE and BChE inhibition compared to tacrine (IC50 = 19.74 µM for AChE and 9.85 µM for BChE), with compound 7h emerging as the most potent dual inhibitor (IC50 = 1.07 µM for AChE and 0.86 µM for BChE). Metal chelation studies revealed that several derivatives, particularly halogen-substituted analogs such as 7j, 7f, 7g, 7h, and 7i, showed superior Fe2+ binding activity compared to EDTA. Molecular docking and dynamics studies further confirmed the strong binding affinities of the most active compound 7h within the active sites of AChE and BChE. In addition, DFT calculations revealed that 7h possesses a small HOMO-LUMO energy gap and a high electrophilicity (ω) index, indicating favorable electronic reactivity and a strong tendency for charge-transfer interactions with the target enzymes. Cytotoxicity was evaluated against human neuroblastoma (SH-SY5Y) and human umbilical vein endothelial cells (HUVECs), revealing higher sensitivity of SH-SY5Y cells to the tested compounds, with SI values ranging from 3.1 to 9.3.